NCT06207799 2026-02-19Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple MyelomaM.D. Anderson Cancer CenterPhase 2 Recruiting40 enrolled